FOXO4-DRI × kimera chems — lab test, November 2025
Vanguard Laboratory publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 16.89 mg
169% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 4.2 mg using the measured mass, against 2.5 mg on the label — 69% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of FOXO4-DRI from kimera chems, performed by Vanguard Laboratory on November 11, 2025. Reported purity: 99.8%. Net content: 16.89 mg against 10 mg labeled (169% of label). Tested content exceeds the labeled amount by 69%. Batch Black Cap. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of FOXO4-DRI from kimera chems
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| KC-FX4-GRY1 | 26 Oct 2025 | freedomdiagnosticstesting.com | 99.504% | 116% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion